Health

FDA Grants Isturisa (osilodrostat) Expanded Indication for the Treatment of Endogenous Hypercortisolemia in Patients with Cushing’s Syndrome

DailyTrendDailyTrend
Apr 23, 2025 - 14:00
 0  1
FDA Grants Isturisa (osilodrostat) Expanded Indication for the Treatment of Endogenous Hypercortisolemia in Patients with Cushing’s Syndrome
Milan, Italy and Bridgewater, NJ, April 16, 2025 – Today Recordati announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for Isturisa (osilodrostat) for the treatment of endogenous...
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
DailyTrend
DailyTrend

Related Posts

Trump Announces Health Care Records System for Consumers

Trump Announces Health Care Records System for Consumers

DailyTrend Jul 31, 2025  0  0

Susan Monarez Faces Daunting Challenges as C.D.C. Director

Susan Monarez Faces Daunting Challenges as C.D.C. Director

DailyTrend Aug 1, 2025  0  0

New Implant Offers Hope for Easing Rheumatoid Arthritis

New Implant Offers Hope for Easing Rheumatoid Arthritis

DailyTrend Jul 31, 2025  0  0

For Some, Return of Presidential Fitness Test Revives Painful Memories

For Some, Return of Presidential Fitness Test Revives P...

DailyTrend Aug 2, 2025  0  0

Morton Mintz, Muckraking Crusader for Consumers, Dies a...

DailyTrend Jul 30, 2025  0  0

Radioactive Wasps Found at Nuclear Site in South Carolina Could Be a ‘Red Flag,’ Expert Says

Radioactive Wasps Found at Nuclear Site in South Caroli...

DailyTrend Aug 1, 2025  0  0